Skip to main content

Shattuck Labs, Inc.

STTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001680367

In the last 90 days, Shattuck Labs, Inc. insiders filed 0 open-market purchases and 3 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $581.3M in total; no superinvestor holds it.

Holders of 5% or more of STTK

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Shattuck Labs, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of STTK
HolderLatest formStakeChangeFirst filedLatest filingFiling
OrbiMed Advisors LLC13D9.99%6.31M sharesNewSep 2, 20251 filingSep 2, 2025SEC
Prosight Management, LP13G/A9.90%6.54M shares–Nov 13, 20251 filingNov 13, 2025SEC
Redmile Group, LLC13D/A9.90%6.38M shares−1.90 ppfrom 11.80%Aug 6, 20252 filingsAug 26, 2025SEC
Adage Capital Partners GP, L.L.C.13G/A9.79%4.67M shares–Feb 12, 20251 filingFeb 12, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

7 Schedule 13D and 13G filings on Shattuck Labs, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on STTK
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 13, 20257:38 PM ETProsight Management, LPand 4 others13G/A9.90%6.54M shares–Sep 30, 2025SEC
Sep 2, 20259:53 PM ETOrbiMed Advisors LLCand 2 others13D9.99%6.31M sharesNewAug 25, 2025SEC
Aug 26, 20255:01 PM ETRedmile Group, LLCand 2 others13D/A9.90%6.38M shares−1.90 ppfrom 11.80%Aug 25, 2025SEC
Aug 6, 20259:00 PM ETRedmile Group, LLCand 2 others13D/A11.80%5.65M shares–Aug 4, 2025SEC
Jul 29, 20252:32 PM ETVanguard Group Inc13G/A4.48%2.15M shares–Below 5%Jun 30, 2025SEC
Jul 16, 20257:02 PM ETBlackRock, Inc.13G/A1.80%878.8K shares–Below 5%Jun 30, 2025SEC
Feb 12, 20259:33 AM ETAdage Capital Partners GP, L.L.C.and 3 others13G/A9.79%4.67M shares–Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Shattuck Labs, Inc. shares.

No Form 144 notices for Shattuck Labs, Inc. are on file.